IUST Announces Revised Interview Schedule 2026, Check New Date

The Islamic University of Science and Technology (IUST), Kashmir, through its Watson–Crick Centre for Molecular Medicine, has issued an important notice regarding the rescheduling of the interview for the position of Junior Research Fellow (JRF) under Advertisement Notice No. 02 of 2026 dated September 29, 2026.

According to the latest notification issued on October 29, 2026, the interview, which was postponed earlier, has now been rescheduled. All candidates declared eligible in the provisional eligibility list are required to appear for the interview on the newly announced date and time.

Important Details

Rescheduled Date

As per the official notice, the interview for the Junior Research Fellow position, which was postponed earlier, will now be conducted on Tuesday, November 3, 2026, at 10:00 AM.

The interview will take place at the Office Chamber of the Dean Academic Affairs, Islamic University of Science and Technology (IUST), Awantipora.

All candidates whose names appear in the provisional eligibility list and who have been declared eligible for the position are required to attend the interview according to the revised schedule.

Documents Required for Interview

Candidates appearing for the interview must bring their original certificates and testimonials for verification.

Applicants are advised to carry all relevant original documents as specified in the earlier notification to avoid any inconvenience during the verification process.

Eligibility and Earlier Instructions

The university has clarified that the eligibility status of candidates and all other instructions mentioned in the previous notification will remain unchanged.

Therefore, candidates do not need to refer to any revised eligibility criteria, as the latest notice only announces the rescheduled interview date and time.

Project Details

The Junior Research Fellow position is associated with the research project titled:

“Investigate the Therapeutic and Chemo-Sensitizing Efficacy of Unani Pharmacopoeial Formulation Dawa-Ul-Kurkum on Head and Neck Squamous Cell Carcinoma.”

The project focuses on investigating the therapeutic and chemo-sensitizing potential of the Unani pharmacopoeial formulation Dawa-Ul-Kurkum in relation to Head and Neck Squamous Cell Carcinoma.

Official Notice Details

The notification has been issued by Dr. Muzafar Ahmad Macha, Associate Dean, School of Health Sciences and Principal Investigator, IUST.

Candidates are advised to follow the revised interview schedule and ensure their presence at the specified venue on time.